UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2016 (July 20, 2016)
Global Medical REIT Inc.
(Exact name of registrant as specified in its charter)
Maryland | 8091371022 | 46-4757266 |
(State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
4800 Montgomery Lane, Suite 450 Bethesda, MD |
20814 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code | 202-524-6851 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.01 | Completion of an Acquisition or Disposition of Assets |
On July 22, 2016, the Company issued a press release announcing the close of its acquisition on July 20, 2016 of the Berks Eye Surgery Center and Clinic properties and related leaseback transactions for a purchase price of approximately $9.2 million. The properties are located in Wyomissing, Pa. The acquisition was funded using a portion of the proceeds from the Company’s public stock offering that was completed on July 1, 2016.
A copy of the press release is attached as Exhibit 99.1 to this Current Report.
Item 9.01 | Financial Statements and Exhibits |
(d) | Exhibits |
99.1 | Press Release issued on July 22, 2016 relating to the Company’s close of the Berks Eye acquisition in Wyomissing, PA. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Global Medical REIT Inc. | |||
Date: July 22, 2016 | By: | /s/ David Young | |
David Young | |||
Chief Executive Officer (Principal Executive Officer) |